<SEC-DOCUMENT>0000899243-18-016787-index.html : 20180615
<SEC-HEADER>0000899243-18-016787.hdr.sgml : 20180615
<ACCEPTANCE-DATETIME>20180615170028
ACCESSION NUMBER:		0000899243-18-016787
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20180613
FILED AS OF DATE:		20180615
DATE AS OF CHANGE:		20180615

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BRENNAN DANIEL
		CENTRAL INDEX KEY:			0001657999

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33057
		FILM NUMBER:		18902844

	MAIL ADDRESS:	
		STREET 1:		C/O INSYS THERAPEUTICS, INC
		STREET 2:		1333 SOUTH SPECTRUM BLVD, SUITE 100
		CITY:			CHANDLER
		STATE:			AZ
		ZIP:			85286

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CATALYST PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001369568
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		355 ALHAMBRA CIRCLE
		STREET 2:		SUITE 1250
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134
		BUSINESS PHONE:		(305) 529-2522

	MAIL ADDRESS:	
		STREET 1:		355 ALHAMBRA CIRCLE
		STREET 2:		SUITE 1250
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CATALYST PHARMACEUTICAL PARTNERS, INC.
		DATE OF NAME CHANGE:	20110215

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Catalyst Pharmaceutical Partners, Inc.
		DATE OF NAME CHANGE:	20060719
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
Document 1 - file: doc3.html

Document 1 - RAW XML: doc3.xml

</DOCUMENT>
</SEC-DOCUMENT>